Journals / Fırat Tıp Dergisi / 2017 / Cilt: 22 - Sayı: 3

Koroner Arter Hastalarında Plazma Endotelyal Lipaz ve İnflamasyon Belirteçleri Düzeylerinin Değerlendirilmesi

Pages
126–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

C onclusion: According to the findings obtained from the study, it was suggested that changes in plasma inflammatory markers levels may play a role in development and progression of CAD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Evaluation of Plasma Le ve ls of Endothe lial Lipase and Inflammatory Marke rs in Patie nts with C oronary Arte ry O bje ctive: It was aimed to evaluate levels of plasma endothelial lipase (EL) and selected inflammatory markers in coronary artery disease (CAD) in this study.
📊
Key Findings & Data:Mate rial and Method: T he study groups consisted of 88 patients between the ages of 18 and 80 who referred to the Department of Cardiology, Faculty of Medicine at Fırat University with the diagnosis of coronary artery disease, and 88 healthy individuals reported to have no coronary artery disease after angiography.
💡
Conclusion & Impact:C onclusion: According to the findings obtained from the study, it was suggested that changes in plasma inflammatory markers levels may play a role in development and progression of CAD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Evaluation of Plasma Le ve ls of Endothe lial Lipase and Inflammatory Marke rs in Patie nts with C oronary Arte ry O bje ctive: It was aimed to evaluate levels of plasma endothelial lipase (EL) and selected inflammatory markers in coronary artery disease (CAD) in this study. Mate rial and Method: T he study groups consisted of 88 patients between the ages of 18 and 80 who referred to the Department of Cardiology, Faculty of Medicine at Fırat University with the diagnosis of coronary artery disease, and 88 healthy individuals reported to have no coronary artery disease after angiography. Plasma endothelial lipase (EL), interleukin 10 (IL-10), interleukin-6 (IL-6) and high sensitivity C-reactive protein (hsCRP) levels were determined by Enzyme-Linked Immuno Sorbent Assay (ELISA) according to the kit procedure. Re sults: When compared to plasma EL, IL-10, IL-6 and hsCRP levels between control and coronary artery disease group; the levels of IL-6 and hsCRP were increased (p<0.01) however, IL-10 levels decreased statistically significant (p<0.05). In terms of EL levels, there was no statist ically significant relationship found between both groups (p>0.05). C onclusion: According to the findings obtained from the study, it was suggested that changes in plasma inflammatory markers levels may play a role in development and progression of CAD.

Özet

Amaç: Bu çalışmada koroner kalp hastalarının endotelyal lipaz ve seçili diğer inflamatuvar belirteçlerin plazma düzeylerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Çalışma grupları; Fırat Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalına başvuran yaşları 18-80 arasında değişen anjiyografik olarak koroner arter hastalığı tanısı konmuş 88 hasta ile yine anjiyografi sonucu koroner arter hastalığı olmadığı tespit edilmiş 88 sağlıklı bireyden oluşturuldu. Bireylerin plazma örneklerinde, endotelyal lipaz (EL), interlökin 10 (IL-10), IL-6 ve yüksek hassasiyetli C-reaktif protein (hsCRP) düzeyleri enzyme-linked immuno sorbent assay (ELISA) yöntemiyle kit prosedürüne uygun olarak tayin edildi. Bulgular: Plazma EL, IL-10, IL-6 ve hsCRP düzeyleri kontrol ve koroner arter hasta grubunda karşılaştırıldığında; IL-6 ve hsCRP düzeyleri koroner arter hastalarında istatiksel olarak artmış (p 0,05). Sonuç: Çalışmadan elde edilen bulgulara göre plazma inflamatuvar belirteçlerin düzeylerinde meydana gelen değişikliklerin KAH'ın ilerlemesinde ve gelişmesinde rolü olabileceği kanaatine varılabilir.

🔖

Cite This Article

SUSAM, S., İLHAN, N., LLHAN, N., AKBULUT, M. (2017). Koroner Arter Hastalarında Plazma Endotelyal Lipaz ve İnflamasyon Belirteçleri Düzeylerinin Değerlendirilmesi. Fırat Tıp Dergisi, Cilt: 22 - Sayı: 3, 126–130. https://ajindex.com/articles/193391

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2014 update: a re- port from the American Heart Association. Cir- culation 2014; 129: 28-292.
  2. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cho- lesterol transport. Circ Res 2005; 96: 1221-32.
  3. Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in high-density lipop- rotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 2010; 74: 2263-70. Ross R. Atherosclerosis -an inflammatory disea- se. N Engl J Med 1999; 340:115-26.
  4. Tedgui A, Mallat Z. Cytokines in atherosclero- sis: pathogenic and regulatory pathways. Phy- siol Rev 2006; 86: 515-81.
  5. Kanda T, Takahashi T. Interleukin-6 and cardi- ovascular diseases. Jpn Heart J 2004; 45: 183 Ji QW, Guo M, Zheng JS, et al. Downregulation of T helper cell type 3 in patients with acute co- ronary syndrome. Arch Med Res 2009; 40: 285- Kilic T, Ural D, Ural E, et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. He- art 2006; 92: 1041-6.
  6. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: -2. Libby P, Ridker PM. Inflammation and athe- rosclerosis: role of C-reactive protein in risk as- sessment. J Med 2004; 116: 9-16.
  7. Okrainec K, Banerjee DK, Eisenberg MJ. Coro- nary artery disease in the developing world. Am Heart J 2004; 148: 7-15.
  8. Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in high-density lipop- rotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 2010; 74: 2263-70.
  9. Ishida T, Choi SY, Kundu RK, et al. Endothelial lipase modulates susceptibility to atherosclero- sis in apolipoprotein-E-deficient mice. J Biol Chem 2004; 279: 45085-92. van der Giet M, Tolle M, Pratico D, et al. Inc- reased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med 2010; 88: -83. Zhang J, Yu Y, Nakamura K et al. Endothelial lipase mediates HDL levels in normal and hy- perlipidemic rabbits. J Atheroscleros Thrombos.; 19: 213-26.
  10. Ko KW, Paul A, Ma K, Li L. Chan L. Endothe- lial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 2005; 46: 2586-94.
  11. Sugita T, Watarida S, Katsuyama K, Naka